Utah Medical Products, Inc. (NASDAQ:UTMD) Shares Bought by Minerva Advisors LLC

Minerva Advisors LLC boosted its holdings in shares of Utah Medical Products, Inc. (NASDAQ:UTMD) by 85.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 78,389 shares of the medical instruments supplier’s stock after buying an additional 36,061 shares during the period. Utah Medical Products makes up 2.8% of Minerva Advisors LLC’s holdings, making the stock its 12th largest position. Minerva Advisors LLC owned approximately 2.31% of Utah Medical Products worth $4,819,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of the company. Martingale Asset Management L P increased its holdings in shares of Utah Medical Products by 5.3% in the third quarter. Martingale Asset Management L P now owns 3,968 shares of the medical instruments supplier’s stock valued at $266,000 after purchasing an additional 201 shares during the period. Bard Associates Inc. increased its holdings in shares of Utah Medical Products by 1.1% in the third quarter. Bard Associates Inc. now owns 19,781 shares of the medical instruments supplier’s stock valued at $1,329,000 after purchasing an additional 224 shares during the period. Golden State Wealth Management LLC acquired a new position in shares of Utah Medical Products in the fourth quarter valued at about $31,000. BNP Paribas Financial Markets increased its holdings in shares of Utah Medical Products by 102.7% in the third quarter. BNP Paribas Financial Markets now owns 1,117 shares of the medical instruments supplier’s stock valued at $75,000 after purchasing an additional 566 shares during the period. Finally, State Street Corp increased its holdings in shares of Utah Medical Products by 0.9% in the third quarter. State Street Corp now owns 80,856 shares of the medical instruments supplier’s stock valued at $5,434,000 after purchasing an additional 694 shares during the period. 69.60% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Separately, StockNews.com lowered Utah Medical Products from a “strong-buy” rating to a “buy” rating in a report on Thursday, November 7th.

Utah Medical Products Stock Down 0.2 %

Utah Medical Products stock opened at $60.09 on Tuesday. The firm has a market cap of $203.83 million, a price-to-earnings ratio of 15.21 and a beta of 0.08. Utah Medical Products, Inc. has a 52 week low of $58.87 and a 52 week high of $77.33. The business’s 50-day moving average price is $61.42 and its 200 day moving average price is $64.41.

Utah Medical Products (NASDAQ:UTMD) last posted its earnings results on Tuesday, January 28th. The medical instruments supplier reported $0.86 EPS for the quarter. Utah Medical Products had a return on equity of 11.07% and a net margin of 33.92%.

Utah Medical Products Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, April 3rd. Investors of record on Friday, March 14th will be issued a dividend of $0.305 per share. This represents a $1.22 annualized dividend and a yield of 2.03%. The ex-dividend date is Friday, March 14th. Utah Medical Products’s dividend payout ratio (DPR) is 30.89%.

About Utah Medical Products

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.